Tonix Pharmaceuticals Holding Corp.
- TNXP
- NASDAQ
- Biotechnology
- Clinical-Stage Drug Development
- Novel Therapeutics
$6.04
Today −5.92%Quote Oct 16, 2026, 08:00 PM UTC
−47.11%over the last month
Max drawdown −47.1%From 1-month high −47.1%3 months −45.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$103.6M
Quote Oct 16
Next earnings
Nov 9
Expected, not confirmed
Analyst target
$27.00
+347.0% from here
Floor
$6.01
0.5% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TNXPPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
142